MergerLinks Header Logo
Cover Image Joel Marcus
Joel MarcusALEXANDRIA VENTURE INVESTMENTS

Joel Marcus

Executive Chairman and Founder at ALEXANDRIA VENTURE INVESTMENTS

Investor

Deal Bio

Total Deals11
Valued Deals11
Total Value£2,955M
Avg. Deal Size£269M

Sort

United States
Medical Services
Private EquityPrivateAcquisitionMinorityVenture Capital
INSITRO

target

INSITRO

Alexandria Venture Investments

bidder

Alexandria Venture Investments

£116m

38 dealmakers

United States
Biotechnology
Reverse TakeoverMergerAcquisitionDomesticPrivateDe-SPACPrivate Equity
HUMACYTE

target

HUMACYTE

Alpha Healthcare Acquisition

bidder

Alpha Healthcare Acquisition

£618m

48 dealmakers

United States
Biotechnology
MajorityAcquisitionVenture CapitalDomesticPrivate EquityPrivate
C2i Genomics

target

C2i Genomics

The Mark Foundation For Cancer Research

bidder

The Mark Foundation For Cancer Research

£72m

13 dealmakers

United States
Biotechnology
MinorityAcquisitionPrivate EquityPrivateVenture CapitalCross Border
Umoja Biopharma

target

Umoja Biopharma

Cormorant Asset Management

bidder

Cormorant Asset Management

£148m

14 dealmakers

United States
Biotechnology
PrivateMajorityAcquisitionPrivate EquityCross Border
Vividion Therapeutics

target

Vividion Therapeutics

Bayer

bidder

Bayer

£1,437m

47 dealmakers

Canada
Biotechnology
Venture CapitalMinorityPrivate EquityPrivateAcquisitionCross Border
Deep Genomics

target

Deep Genomics

True Ventures

bidder

True Ventures

£130m

12 dealmakers

United States
Biotechnology
Venture CapitalMinorityCross BorderPrivatePrivate EquityAcquisition
Lexeo Therapeutics

target

Lexeo Therapeutics

D1 Capital Partners

bidder

D1 Capital Partners

£72m

15 dealmakers

United States
Biotechnology
AcquisitionVenture CapitalCross BorderPrivatePrivate EquityMinority
Moma Therapeutics

target

Moma Therapeutics

Rock Springs Capital

bidder

Rock Springs Capital

£121m

14 dealmakers

United States
Biotechnology
MinorityVenture CapitalDomesticPrivatePrivate EquityAcquisition
Mozart Therapeutics

target

Mozart Therapeutics

Leaps By Bayer

bidder

Leaps By Bayer

£43m

9 dealmakers

United States
Biotechnology
AcquisitionVenture CapitalCross BorderPrivate EquityMinorityPrivate
Senda Biosciences

target

Senda Biosciences

Samsung Life

bidder

Samsung Life

£101m

11 dealmakers

France
Biotechnology
Venture CapitalPrivateAcquisitionPrivate EquityMinorityCross Border
Imcheck Therapeutics

target

Imcheck Therapeutics

Agent Capital

bidder

Agent Capital

£91m

17 dealmakers

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US